Literature DB >> 9923678

Kainate-receptor-mediated sensory synaptic transmission in mammalian spinal cord.

P Li1, T J Wilding, S J Kim, A A Calejesan, J E Huettner, M Zhuo.   

Abstract

Glutamate, the major excitatory neurotransmitter in the central nervous system, activates three different receptors that directly gate ion channels, namely receptors for AMPA (alpha-amino-3-hydroxy-5-methyl isoxozole propionic acid), NMDA (N-methyl-D-aspartate), and kainate, a structural analogue of glutamate. The contribution of AMPA and NMDA receptors to synaptic transmission and plasticity is well established. Recent work on the physiological function of kainate receptors has focused on the hippocampus, where repetitive activation of the mossy-fibre pathway generates a slow, kainate-receptor-mediated excitatory postsynaptic current (EPSC). Here we show that high-intensity single-shock stimulation (of duration 200 microseconds) of primary afferent sensory fibres produces a fast, kainate-receptor-mediated EPSC in the superficial dorsal horn of the spinal cord. Activation of low-threshold afferent fibres generates typical AMPA-receptor-mediated EPSCs only, indicating that kainate receptors may be restricted to synapses formed by high-threshold nociceptive (pain-sensing) and thermoreceptive primary afferent fibres. Consistent with this possibility, kainate-receptor-mediated EPSCs are blocked by the analgesic mu-opiate-receptor agonist Damgo and spinal blockade of both kainate and AMPA receptors produces antinociception. Thus, spinal kainate receptors contribute to transmission of somatosensory inputs from the periphery to the brain.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9923678     DOI: 10.1038/16469

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  74 in total

1.  Presynaptic kainate receptors regulate spinal sensory transmission.

Authors:  G A Kerchner; T J Wilding; P Li; M Zhuo; J E Huettner
Journal:  J Neurosci       Date:  2001-01-01       Impact factor: 6.167

2.  Two populations of kainate receptors with separate signaling mechanisms in hippocampal interneurons.

Authors:  A Rodríguez-Moreno; J C López-García; J Lerma
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-01       Impact factor: 11.205

3.  Kainate receptor-mediated synaptic currents in cerebellar Golgi cells are not shaped by diffusion of glutamate.

Authors:  I Bureau; S Dieudonne; F Coussen; C Mulle
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

4.  AMPA receptor current density, not desensitization, predicts selective motoneuron vulnerability.

Authors:  W Vandenberghe; E C Ihle; D K Patneau; W Robberecht; J R Brorson
Journal:  J Neurosci       Date:  2000-10-01       Impact factor: 6.167

5.  AMPA receptors and kainate receptors encode different features of afferent activity.

Authors:  Matthew Frerking; Patricia Ohliger-Frerking
Journal:  J Neurosci       Date:  2002-09-01       Impact factor: 6.167

6.  Astrocyte-mediated activation of neuronal kainate receptors.

Authors:  Qing-song Liu; Qiwu Xu; Gregory Arcuino; Jian Kang; Maiken Nedergaard
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-06       Impact factor: 11.205

7.  Gamma oscillations induced by kainate receptor activation in the entorhinal cortex in vitro.

Authors:  Mark O Cunningham; Ceri H Davies; Eberhard H Buhl; Nancy Kopell; Miles A Whittington
Journal:  J Neurosci       Date:  2003-10-29       Impact factor: 6.167

8.  Attenuated plasticity of postsynaptic kainate receptors in hippocampal CA3 pyramidal neurons.

Authors:  Koichi Ito; Anis Contractor; Geoffrey T Swanson
Journal:  J Neurosci       Date:  2004-07-07       Impact factor: 6.167

Review 9.  Neto1 and Neto2: auxiliary subunits that determine key properties of native kainate receptors.

Authors:  Susumu Tomita; Pablo E Castillo
Journal:  J Physiol       Date:  2012-03-19       Impact factor: 5.182

Review 10.  Kainate receptor signaling in pain pathways.

Authors:  Sonia K Bhangoo; Geoffrey T Swanson
Journal:  Mol Pharmacol       Date:  2012-10-24       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.